Wiku Andonotopo, Muhammad Adrianes Bachnas, Julian Dewantiningrum, Mochammad Besari Adi Pramono, Muhammad Ilham Aldika Akbar, Ernawati Darmawan, I Nyoman Hariyasa Sanjaya, Dudy Aldiansyah, Sri Sulistyowati, Milan Stanojevic, Asim Kurjak
{"title":"内分泌干扰物:转化为围产期风险评估的机制。","authors":"Wiku Andonotopo, Muhammad Adrianes Bachnas, Julian Dewantiningrum, Mochammad Besari Adi Pramono, Muhammad Ilham Aldika Akbar, Ernawati Darmawan, I Nyoman Hariyasa Sanjaya, Dudy Aldiansyah, Sri Sulistyowati, Milan Stanojevic, Asim Kurjak","doi":"10.1515/jpm-2025-0259","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To evaluate the evidence linking prenatal exposure to environmental endocrine-disrupting chemicals (EDCs) - including bisphenol A (BPA), phthalates, and per- and polyfluoroalkyl substances (PFAS) - with adverse pregnancy and fetal developmental outcomes, and to assess the potential translation of this evidence into clinical perinatal risk assessment.</p><p><strong>Methods: </strong>A systematic literature search was conducted in PubMed, Scopus, and Web of Science for studies published between January 2000 and May 2025. Eligible studies included epidemiological and experimental research addressing prenatal EDC exposure and fetal-placental outcomes. After duplicate removal and screening, 52 studies met inclusion criteria and were categorized by study type (epidemiological, mechanistic, translational). Data extraction included exposure metrics, critical developmental windows, and reported effect sizes (odds ratios, risk ratios, hazard ratios).</p><p><strong>Results: </strong>Evidence suggests that EDC exposure during early pregnancy is associated with placental dysfunction, altered fetal growth trajectories, endocrine and epigenetic modifications, and increased risk of selected neonatal outcomes. Effect sizes were variable, often modest (many<2.0), but consistently indicated biological plausibility supported by mechanistic data. Biomonitoring studies demonstrate widespread EDC exposure across populations, including higher body burdens in lower-income and racially diverse groups. Despite robust basic science evidence, clinical screening for EDC exposure remains limited, and routine risk assessment frameworks rarely incorporate environmental chemical exposures.</p><p><strong>Conclusions: </strong>Prenatal EDC exposure is biologically linked to disrupted fetal-placental development, yet translation into clinical practice remains incomplete. Integrating environmental exposure assessment and preventive counseling into perinatal care may improve maternal-fetal health and reduce disparities.</p>","PeriodicalId":16704,"journal":{"name":"Journal of Perinatal Medicine","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endocrine disrupting chemicals: translating mechanisms into perinatal risk assessment.\",\"authors\":\"Wiku Andonotopo, Muhammad Adrianes Bachnas, Julian Dewantiningrum, Mochammad Besari Adi Pramono, Muhammad Ilham Aldika Akbar, Ernawati Darmawan, I Nyoman Hariyasa Sanjaya, Dudy Aldiansyah, Sri Sulistyowati, Milan Stanojevic, Asim Kurjak\",\"doi\":\"10.1515/jpm-2025-0259\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To evaluate the evidence linking prenatal exposure to environmental endocrine-disrupting chemicals (EDCs) - including bisphenol A (BPA), phthalates, and per- and polyfluoroalkyl substances (PFAS) - with adverse pregnancy and fetal developmental outcomes, and to assess the potential translation of this evidence into clinical perinatal risk assessment.</p><p><strong>Methods: </strong>A systematic literature search was conducted in PubMed, Scopus, and Web of Science for studies published between January 2000 and May 2025. Eligible studies included epidemiological and experimental research addressing prenatal EDC exposure and fetal-placental outcomes. After duplicate removal and screening, 52 studies met inclusion criteria and were categorized by study type (epidemiological, mechanistic, translational). Data extraction included exposure metrics, critical developmental windows, and reported effect sizes (odds ratios, risk ratios, hazard ratios).</p><p><strong>Results: </strong>Evidence suggests that EDC exposure during early pregnancy is associated with placental dysfunction, altered fetal growth trajectories, endocrine and epigenetic modifications, and increased risk of selected neonatal outcomes. Effect sizes were variable, often modest (many<2.0), but consistently indicated biological plausibility supported by mechanistic data. Biomonitoring studies demonstrate widespread EDC exposure across populations, including higher body burdens in lower-income and racially diverse groups. Despite robust basic science evidence, clinical screening for EDC exposure remains limited, and routine risk assessment frameworks rarely incorporate environmental chemical exposures.</p><p><strong>Conclusions: </strong>Prenatal EDC exposure is biologically linked to disrupted fetal-placental development, yet translation into clinical practice remains incomplete. Integrating environmental exposure assessment and preventive counseling into perinatal care may improve maternal-fetal health and reduce disparities.</p>\",\"PeriodicalId\":16704,\"journal\":{\"name\":\"Journal of Perinatal Medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Perinatal Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1515/jpm-2025-0259\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Perinatal Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1515/jpm-2025-0259","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
目的:评估产前暴露于环境内分泌干扰化学物质(EDCs)(包括双酚A (BPA)、邻苯二甲酸酯、全氟和多氟烷基物质(PFAS))与不良妊娠和胎儿发育结局之间的证据,并评估将这些证据转化为临床围产期风险评估的可能性。方法:系统检索2000年1月至2025年5月在PubMed、Scopus和Web of Science中发表的研究。符合条件的研究包括关于产前EDC暴露和胎儿胎盘结局的流行病学和实验研究。剔除重复和筛选后,52项研究符合纳入标准,并按研究类型(流行病学、机械性、转译性)进行分类。数据提取包括暴露指标、关键发育窗口和报告的效应大小(优势比、风险比、危险比)。结果:有证据表明,妊娠早期暴露于EDC与胎盘功能障碍、胎儿生长轨迹改变、内分泌和表观遗传改变以及某些新生儿结局的风险增加有关。结论:产前EDC暴露在生物学上与胎儿胎盘发育中断有关,但转化为临床实践仍不完整。将环境暴露评估和预防性咨询纳入围产期护理可改善母胎健康并减少差异。
Endocrine disrupting chemicals: translating mechanisms into perinatal risk assessment.
Objectives: To evaluate the evidence linking prenatal exposure to environmental endocrine-disrupting chemicals (EDCs) - including bisphenol A (BPA), phthalates, and per- and polyfluoroalkyl substances (PFAS) - with adverse pregnancy and fetal developmental outcomes, and to assess the potential translation of this evidence into clinical perinatal risk assessment.
Methods: A systematic literature search was conducted in PubMed, Scopus, and Web of Science for studies published between January 2000 and May 2025. Eligible studies included epidemiological and experimental research addressing prenatal EDC exposure and fetal-placental outcomes. After duplicate removal and screening, 52 studies met inclusion criteria and were categorized by study type (epidemiological, mechanistic, translational). Data extraction included exposure metrics, critical developmental windows, and reported effect sizes (odds ratios, risk ratios, hazard ratios).
Results: Evidence suggests that EDC exposure during early pregnancy is associated with placental dysfunction, altered fetal growth trajectories, endocrine and epigenetic modifications, and increased risk of selected neonatal outcomes. Effect sizes were variable, often modest (many<2.0), but consistently indicated biological plausibility supported by mechanistic data. Biomonitoring studies demonstrate widespread EDC exposure across populations, including higher body burdens in lower-income and racially diverse groups. Despite robust basic science evidence, clinical screening for EDC exposure remains limited, and routine risk assessment frameworks rarely incorporate environmental chemical exposures.
Conclusions: Prenatal EDC exposure is biologically linked to disrupted fetal-placental development, yet translation into clinical practice remains incomplete. Integrating environmental exposure assessment and preventive counseling into perinatal care may improve maternal-fetal health and reduce disparities.
期刊介绍:
The Journal of Perinatal Medicine (JPM) is a truly international forum covering the entire field of perinatal medicine. It is an essential news source for all those obstetricians, neonatologists, perinatologists and allied health professionals who wish to keep abreast of progress in perinatal and related research. Ahead-of-print publishing ensures fastest possible knowledge transfer. The Journal provides statements on themes of topical interest as well as information and different views on controversial topics. It also informs about the academic, organisational and political aims and objectives of the World Association of Perinatal Medicine.